Ryan Dunlap - 25 Aug 2022 Form 3 Insider Report for CytoDyn Inc. (CYDY)

Reporting relationship
Director
Issuer ticker
CYDY
Reported as of
25 Aug 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
06 Sep 2022, 19:28:41 UTC
Next SEC filing
08 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Antonio Migliarese, Attorney-in-Fact

Key filing fact

Ryan Dunlap filed Form 3 for CytoDyn Inc. (CYDY) on 06 Sep 2022.

Key facts

  • This page summarizes Ryan Dunlap's Form 3 filing for CytoDyn Inc. (CYDY).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Sep 2022, 19:28.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Additional SEC filing notes

Filing notes and footnotes

Ownership status

The filing reports no beneficially owned securities.

SEC remarks

EX 24- Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .